SBC Medicals EBITDA 2023-2025 | SBC
SBC Medicals ebitda from 2023 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
SBC Medicals Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $74 |
| 2023 | $83 |
| 2022 | $-1 |
|
SBC Medicals Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $17 |
| 2025-06-30 | $15 |
| 2025-03-31 | $25 |
| 2024-12-31 | $6 |
| 2024-09-30 | $15 |
| 2024-06-30 | $28 |
| 2024-03-31 | $25 |
| 2023-12-31 | $54 |
| 2023-09-30 | $20 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.459B | $0.205B |
| SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.580B | 31.14 |
| HCA Healthcare (HCA) | United States | $106.416B | 17.62 |
| CVS Health (CVS) | United States | $104.957B | 12.07 |
| Elevance Health (ELV) | United States | $82.726B | 12.13 |
| Cencora (COR) | United States | $68.377B | 22.04 |
| Natera (NTRA) | United States | $33.600B | 0.00 |
| DiDi Global (DIDIY) | China | $23.532B | 21.74 |
| Labcorp Holdings (LH) | United States | $22.381B | 17.07 |
| Medpace Holdings (MEDP) | United States | $17.078B | 42.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.157B | 0.00 |
| Viatris (VTRS) | United States | $15.249B | 5.68 |
| ICON (ICLR) | Ireland | $15.081B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.921B | 13.51 |
| Revvity (RVTY) | United States | $13.350B | 24.58 |
| CochLear (CHEOY) | Australia | $12.343B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.026B | 21.24 |
| Avantor (AVTR) | United States | $8.345B | 12.75 |
| Sonic Healthcare (SKHHY) | Australia | $7.987B | 0.00 |
| HealthEquity (HQY) | United States | $7.383B | 27.61 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.209B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.089B | 39.98 |
| PACS (PACS) | United States | $5.503B | 33.47 |
| Sotera Health (SHC) | United States | $5.369B | 25.89 |
| Alignment Healthcare (ALHC) | United States | $4.724B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.945B | 51.72 |
| Concentras Parent (CON) | United States | $2.785B | 17.38 |
| Organon (OGN) | United States | $2.532B | 2.67 |
| Progyny (PGNY) | United States | $2.155B | 42.37 |
| Surgery Partners (SGRY) | United States | $2.044B | 26.33 |
| Establishment Labs Holdings (ESTA) | United States | $1.960B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.907B | 11.39 |
| Ardent Health (ARDT) | United States | $1.236B | 4.03 |
| Nutex Health (NUTX) | United States | $1.127B | 8.62 |
| Teladoc Health (TDOC) | United States | $1.127B | 0.00 |
| CareDx (CDNA) | United States | $1.081B | 17.66 |
| Omada Health (OMDA) | United States | $0.930B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.872B | 14.28 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.715B | 4.07 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.685B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.596B | 0.00 |
| Enhabit (EHAB) | United States | $0.560B | 25.16 |
| CryoPort (CYRX) | United States | $0.547B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.419B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.311B | 65.42 |
| Shoulder Innovations (SI) | United States | $0.310B | 0.00 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.174B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.088B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.55 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |